Linking Ubiquitin Research to Drug Discovery

Home » News & Events

ELRIG networking event

Posted on November 29th, 2017 in Events
“PROTACs – An exciting therapeutic modality” Ubiquigent will be attending and presenting at the upcoming ELRIG networking event, organised in association with AstraZeneca The event is free to attend and will be held at the Alderley Park Conference Centre on… Read more

Enzymes in Drug Discovery Summit

Posted on November 29th, 2017 in Events
Ubiquigent will be attending and presenting at the upcoming GTC - Enzymes in Drug Discovery Summit, which will take place on February 22nd-23rd, 2018 in San Diego, CA. Jason Brown (Scientific Director), will present an overview of Ubiquigent's activities in… Read more

BioEurope Berlin

Posted on October 30th, 2017 in Events
Ubiquigent will be attending the upcoming Bio Europe meeting (November 6-8, 2017), Berlin. If you’d like to discuss how our approach can support your ubiquitin-focused drug discovery projects please contact us via the partnering portal. For full details of the… Read more

15th Annual Discovery on Target

Posted on September 21st, 2017 in Events
Ubiquigent will be attending and presenting at the upcoming Discovery on Target meeting (September 25– 29, 2017), Boston, MA. Come and see Jason Brown (Scientific Director) discuss ‘An Integrated Chemistry and Assay Platform to Enable and Support Ubiquitin-System Targeted Drug… Read more

Ubiquitin focused drug discovery

Posted on August 3rd, 2017 in News
Targeting kinase enzymes has grown to dominate drug discovery over the last decade, accounting for 30% of current pharma R&D Click on the link below to download our brochure detailing "The Unbiquitin System" and how "The analogous ubiquitin cell signalling… Read more

DUBtarget™-001 – a novel DUB focused compound library

Posted on August 3rd, 2017 in News
The first compound library comprising novel small molecules designed to target deubiquitylase enzymes Click on the link below to download a non-confidential summary of DUBtarget™-001 which includes details of how the library was designed and characterised by screening it using… Read more

SCI: Targeting the Ubiquitin-Proteasome Pathway (19th May 2017)

Posted on March 31st, 2017 in Events
Ubiquigent will be attending and presenting at the upcoming SCI meeting - Targeting the Ubiquitin - Proteasome Pathway on 19th May 2017 at the Studio, Birmingham. If you would like to hear more about our novel ubiquitin system compound libraries… Read more

Ubiquigent awarded Innovate UK grant

Posted on January 19th, 2017 in News
Ubiquigent awarded Innovate UK grant to develop novel compound libraries targeting deubiquitylase (DUB) enzymes Dundee, UK, 19th January 2017: Ubiquigent Limited, a company specialising in providing ubiquitin cell-signalling system drug discovery services and research tools, announced today that it has… Read more

Ubiquigent attending Bio Europe 2016 – Cologne, Germany (7th-9th Nov)

Posted on October 31st, 2016 in Events
We will be attending the upcoming Bio Europe 2016 conference in Cologne, Germany from 7th - 9th November. Full details of the conference can be found here. If you would like to meet with us at Bio Europe, please either contact us… Read more

Ubiquigent launches first novel compound library

Posted on September 14th, 2016 in News
Ubiquigent launches the first novel compound library designed to target Deubiquitylase (DUB) enzymes - DUBtarget™-001 Dundee, UK, 14th September, 2016: Ubiquigent Limited, a company specialising in providing ubiquitin cell-signalling system drug discovery services and research tools, announced today that it… Read more